About Antev
Antev is a company based in London (United Kingdom) founded in 2013 by Oliver Bates was acquired by Medicus Pharma in April 2025.. The company has 9 employees as of December 31, 2020. Antev operates in a competitive market with competitors including Lipella, TheraVida, Esprit Pharma, Regenfro Co and Kissei Pharmaceutical, among others.
- Headquarter London, United Kingdom
- Employees 9 as on 31 Dec, 2020
- Founders Oliver Bates
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Antev Limited
- Date of Incorporation 06 Nov, 2013
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
9
as on Dec 31, 2020
-
Acquired by
Medicus Pharma
(Apr 28, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Antev
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Antev
Antev has secured backing from 1 investor. Prominent investors backing the company include Medicus Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies in the biotechnology and life sciences industry
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Antev
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Antev
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Antev Comparisons
Competitors of Antev
Antev operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lipella, TheraVida, Esprit Pharma, Regenfro Co and Kissei Pharmaceutical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Lipid-based therapies for common bladder syndromes are developed.
|
|
| domain | founded_year | HQ Location |
Clinical stage biopharma company developing drugs for urology and central nervous system disorders
|
|
| domain | founded_year | HQ Location |
Develop drugs for genitourinary (GU) disorders
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics to treat renal diseases
|
|
| domain | founded_year | HQ Location |
Therapies for renal diseases and urology-related anemia are developed.
|
|
| domain | founded_year | HQ Location |
Develops pharmaceuticals for urology, hormone replacement therapy, and female sexual dysfunction treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Antev
Frequently Asked Questions about Antev
When was Antev founded?
Antev was founded in 2013.
Where is Antev located?
Antev is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
How many employees does Antev have?
As of Dec 31, 2020, the latest employee count at Antev is 9.
What does Antev do?
Antev is a biotechnology company with a focus on urology. The companys flagship products are based on a technology called as Teverelix, a patented and proprietary long-acting GnRH (gonadotrophin releasing hormone) antagonist and targeted for the indications of benign prostatic hyperplasia and acute urinary retention. Teverelix has completed phase II is ready to undergo phase III trials for benign prostatic hyperplasia, prostate cancer phase I for endometriosis. The company is also trying to useTeverelix for veterinary applications.
Who are the top competitors of Antev?
Antev's top competitors include Lipella, Kissei Pharmaceutical and Regenfro Co.
Who are Antev's investors?
Antev has 1 investor. Key investors include Medicus Pharma.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.